781TiP AGADIR: A basket multicenter open-label phase II study evaluating the first in class TLR7/8 agonist BDB001 in combination with atezolizumab and stereotactic body radiation therapy in patients with advanced solid tumors

Autor: A. Italiano, C. Coutzac Bergouignan, D. Pasquier, P. Rochigneux, M.P. Sablin, C.A. Gomez-Roca, F. Ghiringhelli, J-P. Metges, M. Toulmonde, S. Cousin, S. Pernot, C. Auzanneau, B. Lortal, M. Kind, P. Sargos, S. Batard, A. Petit, P. Gillon, S. Albert, M. Pulido
Rok vydání: 2022
Předmět:
Zdroj: Annals of Oncology. 33:S898
ISSN: 0923-7534
DOI: 10.1016/j.annonc.2022.07.907
Databáze: OpenAIRE